1. Ständige Impfkommission STIKO: Aktualisierte Hinweise für Ärzte zum Aufklärungsbedarf über mögliche unerwünschte Wirkungen bei Schutzimpfungen. Epidemiol Bull 2007; 25.
2. Stajich GV, Lopez GJ, Harry WW, Sexson WR: Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr 2000; 136: 679–81.
3. The European Agency for the Evaluation of Medicinal Products – Evaluation of Medicines for Human Use. CPMP position paper on thiomersal – implementation of the warning statement relating to sensitisation. CPMP/2612/99. www.eudra.org/emea.html
4. Hernán MA, Jick SS, Olek MJ, Jick H: Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Neurology 2005; 63: 838–42.
5. DeStefano F, Weintraub ES, Chen RT: Determining risk of multiple sclerosis after hepatitis B vaccine: time since vaccination and source of data. Pharmacoepidemiol Drug Saf 2004; 13:143.